Communicating Scientific Discoveries
ViaCyte’s scientists and other experts have published key findings in the field of stem cell engineering.
- Agulnick et al. Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo. Stem Cell Translational Medicine 2015 Oct;4(10):1214-22
- T. Schulz. Concise Review: Manufacturing of Pancreatic Endoderm Cells for Clinical Trials in Type 1 Diabetes. Stem Cell Translational Medicine 2015 Aug;4(8):927-31.
- T. Schulz et al. A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells. Public Library of Science One (2012), Vol 7, Issue 5, e37004.
- Kelly et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nature Biotechnology (2011), 29: 750-756.
- McCall et al. Are stem cells a cure for diabetes? Clinical Science (2010), 118: 87-97.
- Baetge. Production of ß-cells from human embryonic stem cells. Diabetes, Obesity and Metabolism (2008),10: 186-194.
- Kroon et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cell in vivo. Nature Biotechnology (2008), 26: 443-452.
- McLean et al. Activin A efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells (2007), 25: 29-38.
- D’Amour et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology (2006), 24: 1392-1401.
- D’Amour et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnology (2005), 23: 1534-1541.